May 15, 2026
7:6
For every 6 shares held, investors received 7. The price per share adjusted from $0.42 to $0.36.
The split itself did not change the total investment value.
Biogen Pharmachem Industries Limited (BSE:BIOGEN) operates in the Investment banks/Brokers industry.
Biogen Pharmachem Industries Limited company overviewBiogen Pharmachem Industries Limited's most recent stock split was on May 15, 2026. It was a 7-for-6 forward split, so shareholders received 7 shares for every 6 they held.
Biogen Pharmachem Industries Limited has split its stock once. This history records one forward split, on May 15, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Biogen Pharmachem Industries Limited's 7-for-6 split on May 15, 2026, every 6 shares became 7 shares.
Biogen Pharmachem Industries Limited has not announced a new split in our records. Its most recent split was on May 15, 2026, less than a year ago. Companies announce splits in advance, and any new BSE:BIOGEN split will appear on this page.
Already premium?